EllenMBasuMD

Pediatric Hematology & Oncology • New York, NY

Physician

Overview of Dr. Basu

Dr. Ellen Basu is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and New York-Presbyterian Hospital. She received her medical degree from Albert Einstein College of Medicine of Yeshiva University and has been in practice 13 years. Dr. Basu accepts several types of health insurance, listed below. She is one of 95 doctors at Memorial Sloan Kettering Cancer Center and one of 135 doctors at New York-Presbyterian Hospital who specialize in Pediatric Hematology & Oncology. She has more than 40 publications and over 500 citings.

Office
1275 York Avenue
New York, NY 10065
Book by Phone+1(516) 210-4569

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2007 - 2010
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2004 - 2007
Albert Einstein College of MedicineClass of 2004

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2010 - 2025
MA State Medical License 2009 - 2011
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors Start of enrollment: 2011 Aug 15
Completed
Phase 1

Publications & Presentations

PubMed

3 citations
Local anesthesia with general anesthesia for pediatric bone marrow procedures
Sara Zarnegar-Lumley, Katharine R. Lange, Melissa Mathias, Miho Nakajima-Hatano, Katharine M. Offer
Pediatrics. 2019-08-01
53 citations
Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression
Irene Y. Cheung, Nai-Kong V. Cheung, Shakeel Modak, Audrey Mauguen, Yi Feng
Journal of Clinical Oncology. 2021-01-20
24 citations
Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival.
Irene Y. Cheung, Brian H. Kushner, Shakeel Modak, Ellen M. Basu, Stephen S. Roberts
Oncoimmunology. 2017-08-24

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Carelink Health Plans PPO
Empire BCBS HMO
Empire BCBS PPO
First Choice
First Health PPO
GHI PPO
Great West PPO
Health Net Oregon PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
Premera BCBS Heritage & Heritage Plus 1
PriorityHealth HMO
Providence Health System Personal Option
QualCare HMO
QualCare PPO
Regence Washington - Preferred Provider Network
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment